Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 May 2021 | Story Ilze Bakkes

The COVID-19 outbreak in South Africa and the subsequent national lockdown severely impacted the usual physical open day mass-marketing tactic. At the same time, it provided an opportunity for the Department of Student Recruitment Services (SRS) to be super creative and agile in promoting the UFS offerings to the target audiences. 

Once a year, the UFS invites prospective learners and parents to visit our campuses for a taste of campus life. But for many interested students, especially those living remotely or abroad, a site visit is not always practical. Furthermore, the 2021 open days on the Bloemfontein and Qwaqwa Campuses were again cancelled due to the COVID-19 pandemic. The 2020 Virtual Open Day proved that breaking from the traditional recruitment tactics and moving into the virtual domain was not only bold and innovative, but also offered more engagement and communication opportunities with prospective students. Building on the insights and success of COVID-19 response engagements, the Department of Student Recruitment Services has once again developed an immersive virtual experience for prospective students. 

Ilze Bakkes, Chief Officer: Integrated Marketing and Innovation from the Department of Student Recruitment Services, says: “We listened to the needs and wants of our prospective students and staff. Therefore, the 2021 Virtual Expo will have undergraduate, postgraduate, and international student recruitment foci, offering more and relevant information in a visual, multi-layered, and digital way.” Information is presented through videos, photos, downloadable PDF brochures, and links to marketing material and the online application platform. 

A challenge during the physical open day is the lack of time to engage with faculties or that not all the information could be obtained. The Virtual Expo is live now click here and can be visited until 30 September 2021, when applications to study undergraduate and postgraduate programmes in 2022 close. The Virtual Expo offers a professional, easy-to-navigate and hassle-free digital experience of the academic, social, and cultural life at the UFS on all three campuses – in the convenience of the visitor’s own space and time. Subtexts for videos enable differently abled visitors to enjoy the content, and data-sensitive visitors can download the PDF versions of videos. 

Applications to study in 2022 are already open. To apply, click here (link to online application). For important closing dates, download the UFS Undergraduate Prospectus

For information on the Virtual Expo, contact Ilze Bakkes at +27 51 401 9028 or bakkese@ufs.ac.za.

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept